Skip to Content

692 (Divalproex Sodium Extended-Release 500 mg)

Pill with imprint 692 is White, Capsule-shape and has been identified as Divalproex Sodium Extended-Release 500 mg. It is supplied by Global Pharmaceuticals.

Divalproex sodium is used in the treatment of bipolar disorder; mania; migraine prevention; epilepsy; cyclothymic disorder (and more), and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 500 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 692

Divalproex Sodium Extended-Release

Imprint:
692
Strength:
500 mg
Color:
White
Size:
6.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Fatty acid derivative anticonvulsants
Pregnancy Category:
D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder
X - Not for use in pregnancy - When treating migraine
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Global Pharmaceuticals
Inactive Ingredients:
silicon dioxide
copovidone
calcium phosphate dihydrate dibasic
hydrogenated cottonseed oil
hypromellose
polyethylene glycol
polyvinyl alcohol
magnesium silicate
titanium dioxide
microcrystalline cellulose
stearic acid
xanthan gum
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide